Further Decision Processed by IB
05/03/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
ST13
US500000079158397Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of the wording "VIFOR PHARMA". To the left of the wording is a design element of three horizontal straight lines stacked on top of each other.
Holders
Representatives
Timothy J. Kelly Fitzpatrick, Cella, Harper & Scinto
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifrices
Class 5
Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectants
Class 35
Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparations
Class 39
Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparations
Class 41
Business training services as relating to pharmaceutical and sanitary products
Class 42
Research and development of medicines, pharmaceutical preparations and sanitary care products for others
Class 45
Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicines
History of USPTO decisions and trademark events.
46 publications found
05/03/2025
GENERIC MADRID TRANSACTION SENT TO IB
03/21/2025
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/21/2025
GENERIC MADRID TRANSACTION CREATED
03/21/2025
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/18/2023
CANCELLED SECTION 71
11/18/2022
NEW REPRESENTATIVE AT IB RECEIVED
11/30/2021
INTERNATIONAL REGISTRATION RENEWED
09/13/2018
CHANGE OF OWNER RECEIVED FROM IB
10/05/2017
FINAL DECISION TRANSACTION PROCESSED BY IB
02/17/2017
FINAL DISPOSITION NOTICE SENT TO IB
08/09/2016
FINAL DISPOSITION PROCESSED
08/09/2016
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/03/2016
REGISTERED-PRINCIPAL REGISTER
05/03/2016
PUBLISHED FOR OPPOSITION
02/16/2016
NOTIFICATION PROCESSED BY IB
02/12/2016
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2016
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/27/2016
NOTICE OF PUBLICATION
01/27/2016
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/13/2016
EXAMINER'S AMENDMENT ENTERED
01/11/2016
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2016
EXAMINER'S AMENDMENT ENTERED
01/08/2016
EXAMINERS AMENDMENT MAILED
01/07/2016
EXAMINERS AMENDMENT -WRITTEN
01/07/2016
EXAMINERS AMENDMENT -WRITTEN
01/06/2016
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2016
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2016
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/05/2016
FINAL REFUSAL MAILED
07/09/2015
FINAL REFUSAL WRITTEN
07/08/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2015
ASSIGNED TO LIE
06/01/2015
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/27/2015
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2015
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2015
REFUSAL PROCESSED BY IB
02/06/2015
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2015
REFUSAL PROCESSED BY MPU
01/13/2015
APPLICATION FILING RECEIPT MAILED
01/13/2015
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2015
NON-FINAL ACTION WRITTEN
01/10/2015
ASSIGNED TO EXAMINER
01/08/2015
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2015
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/02/2015
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.